Company news

Lucid Diagnostics Inc. news in 2025

Lucid Diagnostics Inc.'s news releases, calls and decks from 2025, newest first.

View company

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection

December 9, 2025

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree

November 20, 2025

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

November 13, 2025

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results

November 12, 2025

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results

November 12, 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025

October 29, 2025

Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit

October 15, 2025

Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors

September 25, 2025

Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs

September 16, 2025

Lucid Diagnostics Announces Closing of Public Offering of Common Stock

September 11, 2025

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

September 10, 2025

Lucid Diagnostics Announces Proposed Public Offering of Common Stock

September 9, 2025

Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025

September 5, 2025

Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025

August 27, 2025

PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results

August 13, 2025

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results

August 13, 2025

Lucid Diagnostics to Participate in Upcoming Investor Conferences

August 5, 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025

July 30, 2025

MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test

July 16, 2025

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test

June 18, 2025

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes

May 27, 2025

Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results

May 14, 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025

April 30, 2025

NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD

April 24, 2025

Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

April 3, 2025

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology

March 27, 2025

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

March 24, 2025

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

March 24, 2025

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening

March 20, 2025

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

March 18, 2025

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test

March 13, 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025

March 10, 2025

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering

March 5, 2025

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering

March 4, 2025

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD

February 27, 2025

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement

February 25, 2025

Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health

February 20, 2025

Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

February 5, 2025

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

January 12, 2025

Calls in 2025

Decks in 2025